These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 12500404)

  • 1. [Clinical analysis of 57 patients with ovarian dysgerminoma].
    Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
    Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early recurrent factors of ovarian cancer after treatment].
    Zhang JQ; Li L; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1201-3. PubMed ID: 14613653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
    Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dysgerminoma of the ovary: a clinical retrospective analysis of 60 cases].
    Zhang R; Hong W; Li S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):550-2. PubMed ID: 8556917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in granulosa cell tumor of the ovary].
    Wu L; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):673-6. PubMed ID: 11218897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on management of low potential malignancy ovarian tumors].
    Takahashi A; Ukita M; Nunotani T; Kanto T; Natsuyama S
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1797-802. PubMed ID: 2592805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy].
    Dilhuydy JM; Lagarde P; Chauvergne J; Mongodin B; Dilhuydy MH; Coindre JM; Avril A; Richaud P; Pigneux J
    Bull Cancer; 1990; 77(3):213-24. PubMed ID: 2340352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma.
    Li H; Hong W; Zhang R; Wu L; Liu L; Zhang W
    Chin Med J (Engl); 2002 Oct; 115(10):1496-500. PubMed ID: 12490095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].
    Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M
    Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysgerminoma of the ovary.
    LaPolla JP; Benda J; Vigliotti AP; Anderson B
    Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysgerminoma: the role of conservative surgery.
    Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
    Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical picture and treatment of ovarian dysgerminoma patients].
    Antoshechkina ET
    Vopr Onkol; 1985; 31(3):68-74. PubMed ID: 3992962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
    Ohta M; Tomoda Y; Kano T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.